Publications by authors named "C Hocke"
Article Synopsis
- * Detection typically involves pelvic ultrasound, with MRI used for detailed mapping prior to surgical or interventional procedures.
- * Treatment is not required if there are no symptoms, but options include medical management, surgery, or uterine artery embolization depending on the severity of symptoms and the need to preserve fertility.
Background: The gynaecological care of women with Multiple Sclerosis has received little attention; most reports focussed on pregnancy or sexuality. The objective of the present study was to evaluate if gynaecological follow-up for women of reproductive age with Multiple Sclerosis was adequate.
Methods: We performed a cross-sectional study on a large cohort of women with Multiple Sclerosis aged 18-40 years.
Percutaneous cryoablation of symptomatic uterine adenomyomas: Initial experience.
J Gynecol Obstet Hum Reprod
March 2024
Objective: To assess the efficacy and safety of percutaneous image-guided cryoablation of adenomyomas MATERIAL AND METHODS: Five symptomatic women who wanted to preserve their uterus and fertility underwent a single session of percutaneous image-guided cryoablation of adenomyoma. Three to six 17-gauge cryoprobes were introduced percutaneously into the adenomyoma under ultrasound and laparoscopy guidance. Clinical efficacy was defined as the diminution of the Visual Analogue Scale of pain (VAS), the decrease in uterine bleeding and the improvement of quality of life assessed by the endometriosis health profile 5 (EHP-5) 12 months after treatment.
View Article and Find Full Text PDFProspective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF/ICSI procedures (DELTA Study).
Eur J Obstet Gynecol Reprod Biol
February 2024
Article Synopsis
- The study evaluated the use and effectiveness of follitropin delta in women undergoing IVF or ICSI, focusing on its safety and dosing patterns in clinical practice after one treatment cycle.
- Conducted in France across 14 centers, 248 women were treated, with 223 being analyzed; the study highlighted that a significant majority of patients followed a standardized dosing algorithm.
- Key findings included an average of 11.3 oocytes retrieved per patient, a clinical pregnancy rate of 35%, and an ongoing pregnancy rate of 29.6%, indicating good efficacy and safety of follitropin delta in IVF/ICSI treatments.
Update on the management of endometriosis-associated pain in France.
J Gynecol Obstet Hum Reprod
November 2023
Article Synopsis
- The French National College of Obstetricians and Gynecologists updated their guidelines in 2018 to manage endometriosis pain, now incorporating new therapies and research up to 2021.
- A new diagnostic approach using patient questionnaires and saliva analysis may help identify pelvic pain issues without the need for surgery.
- Dienogest (DNG) is recognized as an effective first-line treatment for endometriosis pain, and new oral GnRH antagonists are expected to hit the French market soon, offering rapid results with easier administration compared to existing treatments.